IndraLab

Statements


SCN5A activates PSMD4. 2 / 2
| 2

reach
"Chronic treatment with oral flecainide was recommended to both patients; both refused this approach unless new episodes of atrial arrhythmia occurred.In this report we describe, for the first time, a [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"The pacing-control group exhibited shortened AERP, decreased CV, increased AF inducibility and tissue fibrosis, and down-regulated L-type Ca (2+) channel (LCC), SCN5A, Kv4.3 and connexin43 (Cx43)."